Navigation Links
Daktari Accepted into WHO Prequalification of Diagnostics Programme
Date:7/18/2014

CAMBRIDGE, Mass., July 18, 2014 /PRNewswire/ -- Daktari Diagnostics is pleased to announce the acceptance of the Daktari CD4 Instrument into the Prequalification of Diagnostics Programme within the World Health Organization (WHO). The Daktari CD4 is a portable and wirelessly connected point-of-care diagnostic platform that can deliver a patient's CD4 cell count in less than 15 minutes, all from a single drop of blood.

The Daktari CD4 is geared toward resource-limited settings and is the first of Daktari's point-of-care technologies to enter the commercialization phase.

Facilitated through the Diagnostics and Laboratory Technology Team (DLT) within the department of Essential Health Technologies (EHT), the goal of the WHO Prequalification of Diagnostics program is to encourage and simplify access to safe, inexpensive, and high quality diagnostic devices intended to address the most pressing global diseases. As part of the WHO Prequalification of Diagnostics Programme, the Daktari CD4 will undergo extensive and thorough evaluation in hopes of receiving prequalification status of diagnostics. If approved, the Daktari CD4 will be eligible for procurement in United Nations' tenders.

"We are thrilled that the Daktari CD4 has been accepted into the WHO Prequalification of Diagnostics Programme," said Betsy Wonderly, Daktari's Global Product Manager. "Our team has been working incredibly hard day in and day out to bring the Daktari CD4 to those who need it the most, and being a part of the Prequalification of Diagnostics Programme is a big step forward in achieving that goal."

About WHO

WHO is the primary authority for health as part of the United Nations, where its main focus is to offer guidance and direction on global health issues by developing the health research agenda, declaring global health benchmarks, communicating policy options, delivering support to countries and keeping up with global health trends. WHO is governed by The World Health Assembly, which is made up of representatives from 194 Member States. The World Health Assembly meets once each year in Geneva to discuss and solidify guidelines.

About Daktari

Daktari Diagnostics, Inc. (www.daktaridx.com) is a venture-backed company based in Cambridge, USA. Daktari's corporate mission is to address the world's biggest health problems by building a market-leading business around a fleet of accurate, portable diagnostic products that can be deployed anywhere in the world. The Daktari technology platform combines electrochemical sensing with microfluidics, enabling highly accurate, low-cost diagnostics in a handheld format. The Daktari connectivity platform provides seamless data management for results produced at any health facility.

Media Contact

Betsy Wonderly
Daktari Diagnostics
media@daktaridx.com
+1 (617) 336-3299

Photo - http://photos.prnewswire.com/prnh/20140325/NE90169-a
Logo - http://photos.prnewswire.com/prnh/20140325/NE90169LOGO-b


'/>"/>
SOURCE Daktari Diagnostics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. New Drug Application For Naloxegol Accepted By United States Food And Drug Administration
2. Micell Technologies Announces DESSOLVE I Manuscript Accepted for Publication in American College of Cardiologys Cardiovascular Interventions Journal
3. New Drug Application Filing for Ibrutinib Accepted in Two B-cell Malignancies by the U.S. FDA
4. Actavis NDA for Progestin-Only Patch Accepted for Filing by FDA
5. Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
6. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
7. CardioChek Test System Accepted by HEART UK for Use in Nationwide Program
8. Beckman Coulter to Acquire Siemens Healthcare Diagnostics Clinical Microbiology Business
9. Decline in Prescription Drug Misuse More than Twice as High in States with Broad Drug Abuse Prevention Programs, New Quest Diagnostics Health Trends Study Finds
10. Diagnostics Market in Transition--Amid Regulatory Uncertainty and Intensifying Competition
11. Diomics Announces Issuance Of U.S. Patents For Novel Biologic Sample DNA Collection Materials For Use In Forensics And Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... EXTON, Pa. , Oct. 12, 2017 ... global leader in innovative solutions for injectable drug administration, ... results before the market opens on Thursday, October 26, ... discuss the results and business expectations at 9:00 a.m. ... 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is ...
(Date:10/11/2017)... Oct. 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... facility in Las Piedras, Puerto Rico ... blades. Following ... facility sustained minor structural damage, temporary loss of power ... have been completed, manufacturing operations have resumed, and the ...
(Date:10/5/2017)... , Oct. 5, 2017  In response to ... Oral and Maxillofacial Surgeons (AAOMS) released prescribing recommendations ... to be used as a first-line therapy to ... Recognizing the value ... White Paper "Opioid Prescribing: Acute and Postoperative Pain ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Global Healthcare ... scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare ... activity. The fun run is geared towards children of all ages; it is ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in post-acute health care, have expanded their existing home health joint venture through ... AccentCare has been operating a joint venture home health company with Asante, delivering ...
Breaking Medicine News(10 mins):